|
yağmurlu Önizleme şey – yönlendirildi göre Jean-Pierre Limosin – Fazla – dil Česky Ελληνικά English Slovenčina Türkçe |
Novo Novo Nordisk (NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
» fazla
TURKISH
Novo
 |